跳至主要内容
临床试验/NCT01668277
NCT01668277终止2 期

Effects of Hypertonic Saline on the Pulmonary Circulation in Children

The Hospital for Sick Children2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2012年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
终止
入组人数
15
试验地点
2
主要终点
Systemic Vascular Resistance Index

研究概览

简要总结

Pulmonary hypertensive crisis is a life-threatening condition, in which the blood pressure in the pulmonary artery, vein, and capillaries. Infusion of hypertonic saline solutions expand the circulating volume, thus allowing more blood to flow and reducing pressure in the artery, vein, and capillaries. Furthermore, infusion of hypertonic saline has been shown to reduce both systemic and pulmonary vascular resistances in adults. If the pulmonary vascular resistance decreases more or to the same degree as the systemic resistance, infusion of hypertonic saline may prove beneficial in the treatment of pulmonary hypertensive crisis. The primary objective of this study is to investigate how a clinically relevant dose of hypertonic saline affects the systemic and pulmonary circulations in children undergoing cardiac catheterization during general anesthesia. This study hypothesizes that an infusion of hypertonic saline over 10 minutes will reduce the pulmonary vascular resistance more than the systemic vascular resistance.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
2 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Children who have had a heart transplant and are scheduled for elective endomyocardial biopsies during general anaesthesia
  • Age > 2 years

排除标准

  • Plasma Na < 130 mmol/l or >150 mmol/l
  • Refusal of consent
  • An estimated pulmonary arterial pressure which is greater than or equal to 66% of systemic blood pressure
  • Children with heart failure (right and/or left), i.e clinical suspicion by either a cardiologist or an anesthesiologist of inability to tolerate a fluid bolus of 3 ml/kg 7.2% NaCl corresponding to an expansion of the circulatory volume by approximately 9% (see the section on safety), which is the equivalent of infusion approximately 20 ml/kg 0.9% NaCl over 10 minutes.

研究组 & 干预措施

3 ml/kg 7.2% NaCl

Experimental

The test fluids 7.2% NaCl 3 ml/kg will be infused over 10 min. The hemodynamic parameters will be determined before and after infusion by a cardiologist blinded to the type of infusion.

干预措施: 7.2% NaCl (Drug)

3 ml/kg 0.9% NaCl

Active Comparator

The test fluids 0.9% NaCl 3 ml/kg will be infused over 10 min. The hemodynamic parameters will be determined before and after infusion by a cardiologist blinded to the type of infusion.

干预措施: 0.9% NaCl (Drug)

20 ml/kg 0.9% NaCl

Active Comparator

The test fluids 0.9% NaCl 20 ml/kg will be infused over 10 min. The hemodynamic parameters will be determined before and after infusion by a cardiologist blinded to the type of infusion.

干预措施: 0.9% NaCl (Drug)

结局指标

主要结局

Systemic Vascular Resistance Index

时间窗: Change from Baseline in Systemic Vascular Resistance Index after 1 hour

Systemic vascular resistance index, a hemodynamic measurement, will be performed during the cardiac catherization.

Cardiac Index

时间窗: Change from Baseline in Cardiac Index after 1 hour

Cardiac index, a hemodynamic measurement, will be performed during the cardiac catherization.

Pulmonary Vascular Resistance Index

时间窗: Change from Baseline in Pulmonary Vascular Resistance Index after 1 hour

Pulmonary vascular resistance index, a hemodynamic measurement, will be performed during the cardiac catherization.

次要结局

  • Blood Gas(Average over 1 hour)
  • Plasma Volume(Average over 1 hour)
  • Atrial Natriuretic Peptide(Average over 1 hour)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Katherine Taylor

Staff Anesthesiologist

The Hospital for Sick Children

研究点 (2)

Loading locations...

相似试验